UNH +0.54% on Nov 12 · Analysis updated Nov 12, 2026, 5:33 PM ET
Why is UnitedHealth Group Incorporated (UNH) stock up?
UnitedHealth Group (UNH) closed at $405.13 on November 12, extending its consolidation above the key $400 psychological mark after testing a low of $388 on November 6. Price action has steadily recovered on diminishing trading volume, reflecting reduced selling pressure following early-month volatility in managed care equities. Operational fundamentals remain constructive, backed by full-year 2026 adjusted EPS guidance upgraded to at least $20.50 and a strong rebound in Optum Health operating profit to $735 million in Q3 from $41 million a year ago. While medical loss ratios and commercial utilization rates remain elevated across the managed care industry, UNH's pricing adjustments, medical care ratio improvement to 88.4%, and solid cash generation support a stable multi-month recovery trajectory.
On the moneyheap blog
- Can Time Series Foundation Models Predict Stock Prices?Can AI predict stock prices? We ran Google's TimesFM 3.0, Amazon's Chronos-2 and Datadog's Toto 2.0 on 24 stocks for two years. Here's what they got right.
News behind the analysis
- UnitedHealth Just Raised Guidance for the Third Time This YearUnitedHealth increased its full-year 2026 adjusted EPS guidance to at least $20.50, driven by an operational turnaround and surging Optum Health operating profit.
- UnitedHealth's Managed Care Turnaround and Dividend ProfileUNH continues to offer an attractive dividend profile with steady margin rebuilding across Medicare Advantage despite broad industry headwinds.
- UnitedHealth's Recovery Gains Traction on Optum Profit SurgeOptum Health third-quarter operating earnings jumped to $735 million from $41 million a year earlier, boosting group profitability.
- Has UnitedHealth Stock Become A Different Bet?UnitedHealth's operating margin improved to 5.8% in Q3 alongside AI integration across Optum, offsetting commercial cost pressures.
- Unitedhealth Group Inc Stock (UNH) Technicals and Sector OutlookManaged care shares faced short-term pressure from elevated medical utilization, while long-term price targets average $474 per share.
- UnitedHealth Group Outperforms Broader Healthcare TrendsWall Street retains a consensus Strong Buy rating on UNH with analysts highlighting 26% expected full-year adjusted EPS growth.
About UNITEDHEALTH GROUP INCORPORATED (Delaware)
UnitedHealth Group is the largest US health insurer by revenue, with roughly $440 billion in expected 2026 revenue. It stands out because it pairs its UnitedHealthcare insurance business with Optum, a large health services arm that runs doctor practices, a pharmacy benefit manager and health data and technology services.
How it makes money
Most of its revenue comes from UnitedHealthcare premiums. These are paid by employers, individuals and the government for Medicare Advantage, Medicaid and commercial health plans. Its profit depends on how much of those premiums goes to pay medical claims, measured by the medical cost ratio (about 88% in Q3 2026). Optum earns money in three ways: Optum Rx manages pharmacy benefits and fills prescriptions, Optum Health provides care through clinics and physician groups (often paid a fixed amount per patient), and Optum Insight sells data, analytics and claims-processing services. Much of Optum's revenue comes from UnitedHealthcare itself. The company also pays a dividend and buys back its own shares.
What usually moves UNH
- Medical cost trends and the medical cost ratio
- Medicare Advantage payment rates and government policy
- Antitrust and regulatory scrutiny, including of Optum
- Optum margin recovery and pharmacy benefit reform
- Quarterly earnings versus guidance